Contact UsCompany ProfileHome
Saaskin Technologies
Send Inquiry Send SMS    Call Me Free
Medtronic Resolute Onyx DES Drug-eluting Stent (SD 2.25) Medtronic Resolute Onyx DES Drug-eluting Stent (SD 2.25) Medtronic Resolute Onyx DES Drug-eluting Stent (SD 2.25)
Medtronic Resolute Onyx DES Drug-eluting Stent (SD 2.25)
Medtronic Resolute Onyx DES Drug-eluting Stent (SD 2.25) Medtronic Resolute Onyx DES Drug-eluting Stent (SD 2.25)

Medtronic Resolute Onyx DES Drug-eluting Stent (SD 2.25)

Product Details:

  • Usage Type Single-use Only
  • Features Thin strut, enhanced visibility, high conformability, deliverability, platinum-iridium core, low-profile delivery system, reduced restenosis risk
  • Accuracy High deployment precision
  • Shelf Life 3 years from date of manufacture
  • Function Restores vessel patency and delivers drug to prevent restenosis
  • Measurement Range Stent size: 2.25 mm diameter, lengths available as per catalog
  • Instruments Type Coronary vascular interventional device
  • Click to View more
X

Medtronic Resolute Onyx DES Drug-eluting Stent (SD 2.25) Price And Quantity

  • Ethylene oxide
  • 2.25 mm
  • 0.84 mm (for SD 2.25 mm)
  • Enhanced with platinum-iridium core
  • Yes
  • Up to 3.0 mm
  • BioLinx® durable polymer with zotarolimus drug
  • Continuous sinusoid technology for uniform scaffolding
  • Yes
  • 0.014" guidewire compatible, compatible with 5 Fr guiding catheter
  • Zotarolimus
  • Sterile, single-use, sealed pouch with outer protective box
  • For use in patients with de novo coronary artery lesions

Medtronic Resolute Onyx DES Drug-eluting Stent (SD 2.25) Product Specifications

  • Zotarolimus Drug-Eluting Stent Technology
  • Store in cool, dry place, away from sunlight, keep in sealed packaging until use
  • Drug-eluting Stent (DES)
  • Lightweight (micro grams range per stent)
  • Coronary vascular interventional device
  • New and Sterile
  • Silent Operation
  • Manual Deployment (via Delivery System)
  • Length varies (typically 8, 12, 15, 18, 22, 26, 30 mm); Diameter 2.25 mm
  • To treat coronary artery disease via percutaneous coronary intervention
  • Stent size: 2.25 mm diameter, lengths available as per catalog
  • Cobalt Chromium Alloy with BioLinx Polymer Coating
  • Yes
  • Yes (Real-time deliverability during PCI)
  • High deployment precision
  • 3 years from date of manufacture
  • Metallic with white polymer coating
  • Restores vessel patency and delivers drug to prevent restenosis
  • Thin strut, enhanced visibility, high conformability, deliverability, platinum-iridium core, low-profile delivery system, reduced restenosis risk
  • No
  • Single-use Only
  • Ethylene oxide
  • 2.25 mm
  • 0.84 mm (for SD 2.25 mm)
  • Enhanced with platinum-iridium core
  • Yes
  • Up to 3.0 mm
  • BioLinx® durable polymer with zotarolimus drug
  • Continuous sinusoid technology for uniform scaffolding
  • Yes
  • 0.014" guidewire compatible, compatible with 5 Fr guiding catheter
  • Zotarolimus
  • Sterile, single-use, sealed pouch with outer protective box
  • For use in patients with de novo coronary artery lesions

Product Description

Brand Medtronic
Stent Diameter (mm) 2.25
Stent Length (mm) 15, 18 & 22
CAT No RONYX22515UX, RONYX22518UX & RONYX22522UX
Catheter Length 300 cm

Resolute Onyx is a drug-eluting stent (DES) that's different by design, optimised for complex PCI, and proven safe and effective in real-world, high bleeding risk patients on 1-month dual antiplatelet therapy (DAPT). Resolute Onyx drug-eluting stent (DES) offers flexibility, conformability, a 2.0-5.0 mm size matrix, and is indicated for high bleeding risk patients and labeled for one-month DAPT



Advanced Drug-Eluting Technology

The Resolute Onyx DES leverages BioLinx polymer combined with zotarolimus to provide a controlled drug release, promoting vessel healing while minimizing neointimal hyperplasia. Its unique technology helps sustain vessel patency and reduces the risk of future blockages. The polymer is durable and biocompatible, ensuring the drug stays localized for optimal therapeutic impact.


Precision and Visibility for Confident Placement

With its platinum-iridium core, this stent delivers enhanced radiopacity, allowing physicians to visualize placement in real-time during PCI. The thin strut architecture and continuous sinusoid design facilitate uniform support, minimize vessel trauma, and improve flexibility, resulting in smoother navigation through tortuous anatomy.


Ease of Use and Reliable Performance

Designed with a low-profile delivery system, the Resolute Onyx DES enables high deliverability and accurate deployment. It is compatible with 0.014" guidewires and 5 Fr guiding catheters, supporting diverse procedural needs. The system is manually deployed and built for single use, ensuring sterility and patient safety in each intervention.

FAQ's of Medtronic Resolute Onyx DES Drug-eluting Stent (SD 2.25):


Q: How does the Medtronic Resolute Onyx DES SD 2.25 stent work in treating coronary artery disease?

A: The stent is deployed via percutaneous coronary intervention to restore blood vessel patency in patients with de novo coronary artery lesions. Its BioLinx polymer coating releases zotarolimus, which suppresses abnormal tissue growth within the stent and reduces the risk of restenosis, helping maintain blood flow.

Q: What are the benefits of the stent's platinum-iridium core and continuous sinusoid design?

A: The platinum-iridium core enhances radiopacity, improving visualization under fluoroscopy for accurate placement. The continuous sinusoid design ensures uniform scaffolding, allowing optimal vessel support, improved flexibility, and a lower risk of vessel injury during deployment.

Q: When is this stent indicated for patient use?

A: The Resolute Onyx DES is indicated for use in patients with de novo coronary artery lesions-new, untreated narrowing of arteries supplying the heart. It's intended to be implanted during a percutaneous coronary intervention (PCI) procedure by a trained clinician.

Q: What are the catheter and vessel size compatibility requirements for this stent?

A: The Resolute Onyx SD 2.25 stent is compatible with a 0.014" guidewire and can be delivered using a 5 Fr guiding catheter. It is suitable for vessel diameters of at least 2.25 mm, with capability for post-dilatation up to 3.0 mm.

Q: How should the stent be stored and prepared for use?

A: The stent should be stored in a cool, dry place, away from direct sunlight, and kept sealed in its original sterile packaging until use. It must not be re-sterilized or reused, as it is intended for single use only.

Q: What is the process for deploying the Resolute Onyx DES during PCI procedures?

A: Deployment is manual and performed over a guidewire. Once properly positioned at the lesion site under imaging, the stent is expanded by inflating the delivery balloon, anchoring it to the vessel wall. The balloon is then deflated and withdrawn, leaving the stent to provide ongoing support and drug delivery.

Q: Where can the Medtronic Resolute Onyx DES SD 2.25 be sourced in India?

A: This stent is available through authorized dealers, distributors, exporters, manufacturers, suppliers, traders, and wholesalers across India. It is supplied in sterile, sealed packaging, ensuring product integrity and safety for each procedure.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Medical Surgicals' category



trade india member
SAASKIN CORPORATION PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.